3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients Iron Sucrose - Epithelial Ovarian Cancer, Anemia | Phase 1 / Phase 2 | Terminated | University of Wisconsin, Madison | 9 | 2019-07-29 | 2023-01-05 |
| Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia V0355 - Iron Deficiency Anemia | Phase 1 | Terminated | Pierre Fabre Medicament | 29 | 2015-08-01 | 2016-09-28 |
| Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery EPO, Feraheme - Anemia, Cardiovascular Disease | Phase 1 / Phase 2 | Terminated | University of Texas Southwestern Medical Center | 5 | 2013-04-09 | 2020-10-23 |
Anemia, Iron-Deficiency (3) · Anemia (2) · Carcinoma, Ovarian Epithelial (1) · Cardiovascular Diseases (1) · Iron Deficiencies (1) · Ovarian Neoplasms (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Iron Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Iron Deficiencies (2) · Adnexal Diseases (1) · Anemia (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1)
Erythropoietin (1) · Ferric Oxide, Saccharated (1) · Ferrosoferric Oxide (1) · ferryl iron (1)
Pierre Fabre Medicament (1) · University of Texas Southwestern Medical Center (1) · University of Wisconsin, Madison (1)
United States (2) · Bulgaria (1) · Romania (1)
Lisa Barroilhet, MD (1) · Philip E. Greilich, MD (1)
2015 (1)